Preformulation Study of the Inclusion Complex Irbesartan-β-Cyclodextrin

被引:46
作者
Hirlekar, Rajashree [1 ]
Kadam, Vilasrao [1 ]
机构
[1] Bharati Vidyapeeths Coll Pharm, Dept Pharmaceut, Navi Mumbai 400614, Maharashtra, India
来源
AAPS PHARMSCITECH | 2009年 / 10卷 / 01期
关键词
beta-cyclodextrin; dissolution; inclusion complex; Irbesartan; solubility;
D O I
10.1208/s12249-009-9206-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the present work was to improve the solubility and dissolution profile of Irbesartan (IRB), a poorly water-soluble drug by formation of inclusion complex with beta-cyclodextrin (beta CD). Phase solubility studies revealed increase in solubility of the drug upon cyclodextrin addition, showing A(L)-type of graph with slope less than one indicating formation of 1:1 stoichiometry inclusion complex. The stability constant (K (s)) was found to be 104.39 M(-1). IRB-beta CD binary systems were prepared by cogrinding, kneading using alcohol, kneading using aqueous alcohol, and coevaporation methods. Characterization of the binary systems were carried out by differential scanning calorimetry, Fourier transform infrared spectroscopy, scanning electron microscopy, X-ray diffraction, and proton nuclear magnetic resonance. The dissolution profiles of inclusion complexes were determined and compared with those of IRB alone and physical mixture. Among the various methods, coevaporation was the best in which the solubility was increased and dissolution rate of the drug was the highest. The study indicated the usefulness of cyclodextrin technology to overcome the solubility problem of IRB.
引用
收藏
页码:276 / 281
页数:6
相关论文
共 13 条
[1]  
[Anonymous], 1965, Advances in Analytical Chemistry and Instrumentation
[2]   The utility of cyclodextrins for enhancing oral bioavailability [J].
Carrier, Rebecca L. ;
Miller, Lee A. ;
Ahmed, Mran .
JOURNAL OF CONTROLLED RELEASE, 2007, 123 (02) :78-99
[3]   Preparation and study on the solid inclusion complex of cloxacillin sodium with β-cyclodextrin [J].
Chao, Jian-Bin ;
Zhang, Bing-Tai .
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2007, 68 (01) :108-112
[4]   A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug [J].
Chawla, Garima ;
Bansal, Arvind K. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 32 (01) :45-57
[5]   Cyclodextrins and their uses: a review [J].
Del Valle, EMM .
PROCESS BIOCHEMISTRY, 2004, 39 (09) :1033-1046
[6]   Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds [J].
Fernandes, CM ;
Vieira, MT ;
Veiga, FJB .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 15 (01) :79-88
[7]   Inclusion complex of trimethoprim with β-cyclodextrin [J].
Li, N ;
Zhang, YH ;
Wu, YN ;
Xiong, XL ;
Zhang, YH .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 39 (3-4) :824-829
[8]   Preparation and characterization of inclusion complexes of prazosin hydrochloride with β-cyclodextrin and hydroxypropyl-β-cyclodextrin [J].
Liu, LX ;
Zhu, SY .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2006, 40 (01) :122-127
[9]  
Loftsson T., 2004, AM J DRUG DELIVERY, V2, P261, DOI [10.2165/00137696-200402040-00006, DOI 10.2165/00137696-200402040-00006]
[10]  
POULEUR HG, 1997, AM J HYPERTENS, V10, P318